Future Outcomes for the Treatment of sJIA, The GOSH Experience

 April 2024         |         Rheumatology

This is a promotional podcast, funded by Sobi and organised in conjunction with EMJ for healthcare professionals in Great Britain, Northern Ireland, and Ireland only. Elements of this podcast will contain promotional content for Kineret®️ (anakinra).

This podcast provides insights on the diagnosis of sJIA (systemic juvenile idiopathic arthritis) and its treatment from real-world experience within Great Ormond Street Hospital (GOSH).

20:42 mins

Prescribing information can be found at:

UK: https://www.medicines.org.uk/emc/product/559
NI : https://www.emcmedicines.com/en-gb/northernireland/medicine?id=3df611b8-45ed-4429-a0b1-0eb1334aae8a&type=smpc
ROI: https://www.medicines.ie/medicines/list/all/page-1/per-page-25?query=Kineret%20

UK

Healthcare professionals are asked to report any suspected adverse reactions. Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard (for United Kingdom). Adverse events should also be reported to Swedish Orphan Biovitrum Ltd at medical.info.uk@sobi.com or Telephone +44 (0) 800 111 4754.

Ireland

Healthcare professionals are asked to report any suspected adverse reactions. Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard (for United Kingdom) and www.hpra.ie (for Republic of Ireland). Adverse events should also be reported to Swedish Orphan Biovitrum Ltd at medical.info.uk@sobi.com or Telephone +44 (0) 800 111 4754.
PP-22465
Date of preparation April 2024